These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 76221)

  • 1. Fetal wastage as a result of an alpha-fetoprotein screening programme.
    Gordon YB; Grudzinskas JG; Kitau MJ; Usherwood MM; Letchworth AT; Chard T
    Lancet; 1978 Apr; 1(8066):677-8. PubMed ID: 76221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Midtrimester amniocentesis: is it safe? A single centre controlled prospective study of 517 consecutive amniocenteses.
    Sant-Cassia LJ; MacPherson MB; Tyack AJ
    Br J Obstet Gynaecol; 1984 Aug; 91(8):736-44. PubMed ID: 6380566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prenatal diagnosis. Amniocentesis.
    McNay MB; Whitfield CR
    Br J Hosp Med; 1984 Jun; 31(6):406-7, 410-11, 13 passim. PubMed ID: 6204708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and accuracy of midtrimester amniocentesis for prenatal diagnosis of genetic disorders.
    Aula P; Karjalainen O; Teramo K; Vaara L; Seppälä M
    Ann Clin Res; 1979 Aug; 11(4):156-63. PubMed ID: 92907
    [No Abstract]   [Full Text] [Related]  

  • 5. Amniotic fluid alpha-fetoprotein levels and pregnancy outcome.
    Brumfield CG; Cloud GA; Finley SC; Cosper P; Davis RO; Huddleston JF
    Am J Obstet Gynecol; 1987 Oct; 157(4 Pt 1):822-5. PubMed ID: 2445206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amniotic fluid cell morphology in early antenatal prediction of abortion and low birth weight.
    Gosden C; Brock DJ
    Br Med J; 1978 Oct; 2(6146):1186-9. PubMed ID: 82463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic use of meternal serum alpha-fetoprotein levels.
    Cowchock FS; Jackson LG
    Obstet Gynecol; 1976 Jan; 47(1):63-8. PubMed ID: 54892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Midtrimester amniocentesis. An analysis of 923 cases with neonatal follow-up.
    Cruikshank DP; Varner MW; Cruikshank JE; Grant SS; Donnelly E
    Am J Obstet Gynecol; 1983 May; 146(2):204-11. PubMed ID: 6189400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of pregnancy outcome after amniocentesis for previous neural tube defect or raised maternal serum alphafetoprotein.
    Read AP; Donnai D; Harris R; Donnai P
    Br J Obstet Gynaecol; 1980 May; 87(5):372-6. PubMed ID: 6155932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum alpha-fetoprotein screening and risk of amniocentesis.
    Brock DJ; Gosden C
    Lancet; 1979 Jul; 2(8135):206. PubMed ID: 89325
    [No Abstract]   [Full Text] [Related]  

  • 11. Significance of meconium in midtrimester diagnostic amniocentesis.
    King CR; Prescott G; Pernoll M
    Am J Obstet Gynecol; 1978 Nov; 132(6):667-9. PubMed ID: 82406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An assessment of the hazards of amniocentesis. Report to the Medical Research Council by their Working Party on Amniocentesis.
    Br J Obstet Gynaecol; 1978; 85 Suppl 2():1-41. PubMed ID: 104726
    [No Abstract]   [Full Text] [Related]  

  • 13. Prenatal serum alpha-fetoprotein screening for neural tube defects.
    Macri JN; Weiss RR
    Obstet Gynecol; 1982 May; 59(5):633-9. PubMed ID: 6175932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hydramnios and fetal malformations. Use of estimating the level of alpha-fetoprotein and of bilirubin in the amniotic fluid during the last trimester of pregnancy (author's transl)].
    Henrion R; Herbinet E; Cédard L; Dallot E; Sender A; Rouvillois JL
    J Gynecol Obstet Biol Reprod (Paris); 1978; 7(7):1207-19. PubMed ID: 84825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Alpha-fetoproteins in maternal serum. Radioimmunologic determination in current obstetrical practice. Analysis of 669 determinations].
    Morin P; Delavest P; Abbou S; Gueris J; Techenet J
    J Gynecol Obstet Biol Reprod (Paris); 1977 Mar; 6(2):193-206. PubMed ID: 69640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prenatal diagnosis of fetal malformations from the obstetrician's viewpoint].
    Winter R
    Wien Klin Wochenschr; 1983 Feb; 95(3):67-78. PubMed ID: 6190319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hazards of amniocentesis.
    Milunsky A
    Lancet; 1979 Mar; 1(8115):546-7. PubMed ID: 85120
    [No Abstract]   [Full Text] [Related]  

  • 18. Risk assessment of amniocentesis between 11 and 15 weeks: comparison to later amniocentesis controls.
    Crandall BF; Kulch P; Tabsh K
    Prenat Diagn; 1994 Oct; 14(10):913-9. PubMed ID: 7534922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fetal loss after second-trimester amniocentesis in women with raised serum-alpha-fetoprotein.
    Bennett MJ
    Lancet; 1978 Nov; 2(8097):987. PubMed ID: 82005
    [No Abstract]   [Full Text] [Related]  

  • 20. Significance of elevated mid-trimester maternal plasma-alpha-fetoprotein values.
    Brock DJ; Barron L; Duncan P; Scrimgeour JB; Watt M
    Lancet; 1979 Jun; 1(8129):1281-2. PubMed ID: 87736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.